The influence of sodium metavanadate on the process of diabetogenesis in BB rats

Journal of Cellular and Molecular Medicine

Volumn 7, Issue 4, 2003, Pages 447-454

  Cheta, Dan ^a,e   Orasanu, Gabriela ^a   Nicolaie, T ^b   Iordachescu, Dana ^c   Buligescu, S ^a   Constantin, C ^b   Hassanain, M ^a   Coman, Anca ^a   Enache, Mihaela ^c   Negru, Raluca ^a   Tica, Valeria ^c   Timofte, Delia ^b   Gutu, Daniela ^a   Panaite, C ^d  

^a Nutrition and Metabolic Diseases 'N Paulescu'   (Romania)

^b Central Military Hospital Bucharest   (Romania)

^c UNIVERSITY OF BUCHAREST   (Romania)

^d CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^e NONE   (Romania)

Author keywords

BB DP rats; Beta cells; Insulin mimetic; Prevention; Sodium metavanadate; Type 1 diabetes

Indexed keywords

ANIMALIA;

INSULIN; VANADIC ACID;

AGE; ANIMAL; ARTICLE; BIOBREEDING RAT; BLOOD; BODY WEIGHT; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; RAT;

AGE FACTORS; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 1; FEMALE; INSULIN; MALE; PREDIABETIC STATE; RATS; RATS, INBRED BB; VANADATES;

EID: 1842853026     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2003.tb00247.x     Document Type: Article

References (31)

1. Cheta D.M., Preventing Diabetes, Theory, Practice and New Approaches, Wiley, Chichester, 1999
2. Cheta D., Orasanu G., Prevention of type 1 diabetes in animal models. In: Cheta D. ed., New Insights into Experimental Diabetes, The Publishing House of the Romanian Academy, Bucharest, 2002, pp. 362-403
3. McNeill J.H., Yuen V.G., Hoveyda H.R., Orvig C., Bis(maltolato) oxovanadium (IV) is a potent insulin mimic, J. Med. Chem., 35:1489-1491, 1992
4. Ramanadham S., Brownsey R.W., Cros G.H., Mongold J.J., McNeill J.H., Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment, Metabolism, 38:1022-1028, 1989
5. Morinville A., Maysinger D., Shaver A., From vanadis to atropos: vanadium compounds as pharmacological tools in cell death signaling, Trends Pharmacol. Sci., 19:452-460, 1998
6. Dai S., Thompson K.H., Vera E., McNeill J.H., Toxicity studies on one-year treatment of non-diabetic and streptozotocin diabetic rats with vanadyl sulphate, Pharmacol. & Toxicol., 75:265-273, 1994
7. Brichard S.M., Henquin J.C., The role of vanadium in the management of diabetes, Trends Pharmacol. Sci., 16:265-270, 1995
8. Li S.H., McNeill J.H., In vivo effects of vanadium on GLUT4 translocation in cardiac tissue of STZ-diabetic rats, Mol. Cell. Biochem., 217:121-129, 2001
9. Wang J., Yuen V.G., McNeill J.H., Effect of vanadium on insulin and leptin in Zucker diabetic fatty rats, Mol. Cell. Biochem., 218:93-96, 2001
10. Shafrir E., Spielman S., Nachliel I., Khamaisi M., Bar-On H., Ziv E., Treatment of diabetes with vanadium salts: general overview and amelioration of nutritionally induced diabetes in the Psammomys obesus gerbil, J. Clin. Endocrinol. Metab., 86:1410-1417, 2001
11. Posner B.I., Peroxovanadium compounds: potent PTP inhibitors with insulin-like effects [Abst.], The EASD Satellite Symposium, Sitges, Barcelona, 9:2000
12. Cam M.C., Rodrigues B., McNeill J.H., Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin- diabetes, Eur. J. Endocrinol., 141:546-554, 1999
13. Sekar N., Li J., Shechter Y., Vanadium salts as insulin substitutes: mechanism of action, a scientific and therapeutic tool in diabetes mellitus research, Crit. Rev. Biochem. Mol. Biol., 31:339-359, 1996
14. Vlahos W.D., Seemayer T.A., Yale J.F., Diabetes prevention in BB rats by inhibition of endogenous insulin secretion, Metabolism, 40:825-829, 1991
15. Meyerovitch J., Waner T., Sack J., Kopolovic J., Shemer J., Attempt to prevent the development of diabetes in non-obese diabetic mice by oral vanadate administration. Isr. Med. Assoc. J., 2:211-214, 2000
16. Blondel O., Bailbe D., Portha B., In vivo insulin resistance in streptozotocin diabetic rats - evidence for reversal following oral vanadate treatment, Diabetologia, 32:185-190, 1989
17. Brichard S.M., Okitolonda W., Henquin J.C., Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats, Endocrinology, 123:2048-2053, 1988
18. Yilmaz M.T., The remission concept in type 1 diabetes and its significance in immune intervention, Diabetes. Metab. Rev., 9:337-348, 1993
19. Sprietsma J.E., Schuitmaker G.E., Diabetes can be prevented by reducing insulin production, Med. Hypotheses, 42:15-23, 1994
20. Cam M.C., Li W.M., McNeill J.H., Partial preservation of pancreatic beta-cells by vanadium: evidence for long-term amelioration of diabetes, Metabolism, 46:769-778, 1997
21. Dai S., Thompson K.H., McNeill J.H., One year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate, Pharmacol. & Toxicol., 75:101-109, 1994
22. Cam M.C., Brownsey R.W., McNeill J.H., Mechanisms of vanadium action: insulin-mimetic or insulin-enhancing " agent?, Can. J. Physiol. Pharmacol., 78:829-847, 2000
23. Brichard S.M., Desbuquois B., Girard J., Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes and on glucose transporter GLUT2, Mol. Cell. Endocrinol., 91:91-97, 1993
24. Mosseri R., Waner T., Shefi M., Shafrir E., Meyerovitch J., Gluconeogenesis in non-obese diabetic (NOD) mice: in vivo effects of vanadate treatment on hepatic glucose-6-phoshatase and phosphoenolpyruvate carboxikinase, Metabolism, 49:321-325, 2000
25. Ramachandran B., Kandaswamy M., Narayanan V., Subramanian S., Insulin mimetic effects of macrocyclic binuclear oxovanadium complexes on streptozotocin-induced experimental diabetes in rats, Diabetes. Obes. Metab., 5:455-461, 2003
26. Cusi K., Cukier S. DeFronzo R.A., Torres M., Puchulu F.M., Redondo J.C., Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes, J. Clin. Endocrinol. Metab., 86:1410-1417, 2001
27. Meyerovitch J., Rothenberg P., Shechter Y., Bonner-Weir S., Kahn KR., Vanadate normalizes hyperglycemia in two mouse models of non-insulin dependent Diabetes Mellitus, J. Clin. Invest., 87:1286-1294, 1991
28. Wang J., Yuen V.G., McNeill J.H., Effect of vanadium on insulin and leptin in Zucker diabetic fatty rats, Mol. Cell. Biochem., 218:93-96, 2001
29. Malabu V.H., Dryden S., McCarthy H.D., Killpatrick A., Williams G., Effects of chronic vanadate administration in the STZ-induced diabetic rat. The antihyperglycemic action of vanadate is attributable entirely to its suppression of feeding, Diabetes, 43:1267-1270, 1994
30. Conconi M.T., DeCarlo E., Vigolo S., Grandi C., Bandoli G., Sicolo N., Tamagno G., Parnigotto P.P., Nussdorfer G.G., Effects of some vanadyl coordination compounds on the in vitro insulin release from rat pancreatic islets, Horm. Metab. Res., 35:402-406, 2003
31. Meyerovitch J., Farfel Z., Sack J., Shechter Y., Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats: characterization and mode of action, J. Biol. Chem., 262:6658-6662, 1987